YongYan Cui, Lauren G. Khanna, Anjali Saqi, John P. Crapanzano, James M. Mitchell, Amrita Sethi, Tamas A. Gonda, Michael D. Kluger, Beth A. Schrope, John Allendorf, John A. Chabot, John M. Poneros
Clin Endosc 2020;53(2):213-220. Published online July 15, 2019
Background /Aims: The management of small, incidentally discovered nonfunctioning pancreatic neuroendocrine tumors (NF-PNETs) has been a matter of debate. Endoscopic ultrasound with fine-needle aspiration (EUS-FNA) is a tool used to identify and risk-stratify PNETs. This study investigates the concordance rate of Ki67 grading between EUS-FNA and surgical pathology specimens in NFPNETs and whether certain NF-PNET characteristics are associated with disease recurrence and disease-related death.
Methods We retrospectively reviewed the clinical history, imaging, endoscopic findings, and pathology records of 37 cases of NFPNETs that underwent pre-operative EUS-FNA and surgical resection at a single academic medical center.
Results There was 73% concordance between Ki67 obtained from EUS-FNA cytology and surgical pathology specimens; concordance was the highest for low- and high-grade NF-PNETs. High-grade Ki67 NF-PNETs based on cytology (p=0.028) and histology (p=0.028) were associated with disease recurrence and disease-related death. Additionally, tumors with high-grade mitotic rate (p=0.005), tumor size >22.5 mm (p=0.104), and lymphovascular invasion (p=0.103) were more likely to have poor prognosis.
Conclusions NF-PNETs with high-grade Ki67 on EUS-FNA have poor prognosis despite surgical resection. NF-PNETs with intermediate-grade Ki67 on EUS-FNA should be strongly considered for surgical resection. NF-PNETs with low-grade Ki67 on EUSFNA can be monitored without surgical intervention, up to tumor size 20 mm.
Citations
Citations to this article as recorded by
Endoscopic Ultrasound-Guided Fine Needle Acquisition for Evaluation of Pancreatic Neuroendocrine Tumors Xiaohua Ye, Hongjun Hua, Chunxiao Hu, Jianying Dai, Chenjiao Wu, Jiaping Huai, Zhe Shen Journal of Clinical Gastroenterology.2025; 59(4): 310. CrossRef
Alternative lengthening of telomeres and Ki‐67 proliferation index provide complementary information on recurrence risk after resection of pancreatic neuroendocrine tumors Hallbera Gudmundsdottir, Rondell P. Graham, Patricia T. Greipp, Elizabeth B. Habermann, Ryan A. Knudson, Carrie A. Brandt, Patrick Starlinger, Cornelius A. Thiels, Susanne G. Warner, Rory L. Smoot, Mark J. Truty, Michael L. Kendrick, David M. Nagorney, Se Journal of Neuroendocrinology.2025;[Epub] CrossRef
Accurate non-invasive grading of nonfunctional pancreatic neuroendocrine tumors with a CT derived radiomics signature Ammar A. Javed, Zhuotun Zhu, Benedict Kinny-Köster, Joseph R. Habib, Satomi Kawamoto, Ralph H. Hruban, Elliot K. Fishman, Christopher L. Wolfgang, Jin He, Linda C. Chu Diagnostic and Interventional Imaging.2024; 105(1): 33. CrossRef
Preoperative Prediction of Lymph Node Metastases in Nonfunctional Pancreatic Neuroendocrine Tumors Using a Combined CT Radiomics–Clinical Model Taha M. Ahmed, Zhuotun Zhu, Mohammad Yasrab, Alejandra Blanco, Satomi Kawamoto, Jin He, Elliot K. Fishman, Linda Chu, Ammar A. Javed Annals of Surgical Oncology.2024; 31(12): 8136. CrossRef
Improving fine needle aspiration to predict the tumor biological aggressiveness in pancreatic neuroendocrine tumors using Ki-67 proliferation index, phosphorylated histone H3 (PHH3), and BCL-2 Chaohui Lisa Zhao, Bahram Dabiri, Iman Hanna, Lili Lee, Zhang Xiaofei, Zarrin Hossein-Zadeh, Wenqing Cao, John Allendorf, Alex Pipas Rodriguez, Katherine Weng, Solomon Turunbedu, Adrienne Boyd, Mala Gupta Annals of Diagnostic Pathology.2023; 65: 152149. CrossRef
Grading Pancreatic Neuroendocrine Tumors Via Endoscopic Ultrasound-guided Fine Needle Aspiration Ammar A. Javed, Alessandra Pulvirenti, Samrah Razi, Jian Zheng, Theodoros Michelakos, Yurie Sekigami, Elizabeth Thompson, David S. Klimstra, Vikram Deshpande, Aatur D. Singhi, Matthew J. Weiss, Christopher L. Wolfgang, John L. Cameron, Alice C. Wei, Amer Annals of Surgery.2023; 277(6): e1284. CrossRef
What Is the Role of Lymph Node Resections in Small Islet Tumors? Alexandra Gangi, Cristina R. Ferrone Advances in Surgery.2023; 57(1): 47. CrossRef
Diagnostic Accuracy of ki-67 Labeling Index in Endoscopic Ultrasonography-Fine-Needle Aspiration Cytology and Biopsy of Pancreatic Neuroendocrine Neoplasms Jung-Soo Pyo, Nae Yu Kim, Kyueng-Whan Min, Il Hwan Oh, Dae Hyun Lim, Byoung Kwan Son Diagnostics.2023; 13(17): 2756. CrossRef
The Utility of Endoscopic-Ultrasonography-Guided Tissue Acquisition for Solid Pancreatic Lesions Hiroki Tanaka, Shimpei Matsusaki Diagnostics.2022; 12(3): 753. CrossRef
A novel tool to predict nodal metastasis in small pancreatic neuroendocrine tumors: A multicenter study Ammar A. Javed, Alessandra Pulvirenti, Jian Zheng, Theodoros Michelakos, Yurie Sekigami, Samrah Razi, Caitlin A. McIntyre, Elizabeth Thompson, David S. Klimstra, Vikram Deshpande, Aatur D. Singhi, Matthew J. Weiss, Christopher L. Wolfgang, John L. Cameron Surgery.2022; 172(6): 1800. CrossRef
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data Matteo Tacelli, Niccolò Bina, Stefano Francesco Crinò, Antonio Facciorusso, Ciro Celsa, Andrea Sbrozzi Vanni, Alberto Fantin, Filippo Antonini, Massimo Falconi, Fabio Monica, Gabriele Capurso, Paolo Giorgio Arcidiacono, Luca Barresi Gastrointestinal Endoscopy.2022; 96(6): 898. CrossRef
Ki-67 Proliferation Index in Fine Needle Aspiration to Predict the Tumor Biological Aggressiveness in Pancreatic Neuroendocrine Tumors Chaohui Lisa Zhao, Bahram Dabiri, Iman Hanna, Zarrin Hossein-Zadeh, Wenqing Cao, Bebu Ram, John Allendorf, Alex Pipas Rodriguez, Adrienne Boyd, Mala Gupta SSRN Electronic Journal.2022;[Epub] CrossRef
Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms Tatsuya Ishii, Akio Katanuma, Haruka Toyonaga, Koki Chikugo, Hiroshi Nasuno, Toshifumi Kin, Tsuyoshi Hayashi, Kuniyuki Takahashi Diagnostics.2021; 11(2): 316. CrossRef
Editors' Choice of Noteworthy Clinical Endoscopy Publications in the First Decade Gwang Ha Kim, Kwang An Kwon, Do Hyun Park, Jimin Han Clinical Endoscopy.2021; 54(5): 633. CrossRef
Current update on imaging for pancreatic neuroendocrine neoplasms Nicole Segaran, Catherine Devine, Mindy Wang, Dhakshinamoorthy Ganeshan World Journal of Clinical Oncology.2021; 12(10): 897. CrossRef
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine‐needle aspiration Wenzel M. Hackeng, Folkert H. M. Morsink, Leon M. G. Moons, Christopher M. Heaphy, G. Johan A. Offerhaus, Koen M. A. Dreijerink, Lodewijk A. A. Brosens Diagnostic Cytopathology.2020; 48(4): 308. CrossRef
Experience and future perspectives on the use of the Papanicolaou Society of Cytopathology Terminology System for reporting pancreaticobiliary cytology Mauro Saieg, Martha B. Pitman Diagnostic Cytopathology.2020; 48(5): 494. CrossRef
Is Endoscopic Ultrasound-Fine Needle Aspiration for Ki67 Aspirational Enough?
Yakira David, Michelle Kang Kim Clinical Endoscopy.2020; 53(2): 111. CrossRef
Clinical relevance of performing endoscopic ultrasound‐guided fine‐needle biopsy for pancreatic neuroendocrine tumors less than 2 cm Charlotte M. Heidsma, Diamantis I. Tsilimigras, Flavio Rocha, Daniel E. Abbott, Ryan Fields, Paula M. Smith, George A. Poultsides, Cliff Cho, Casper van Eijck, Elisabeth Nieveen van Dijkum, Shishir K. Maithel, Timothy M. Pawlik Journal of Surgical Oncology.2020; 122(7): 1393. CrossRef
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases Salvatore Paiella, Luca Landoni, Roberta Rota, Matteo Valenti, Giovanni Elio, Stefano Francesco Crinò, Erminia Manfrin, Alice Parisi, Sara Cingarlini, Mirko D’Onofrio, Aldo Scarpa, Rita Teresa Lawlor, Laura Bernardoni, Paola Capelli, Chiara Nessi, Marco M Endoscopy.2020; 52(11): 988. CrossRef
Background /Aims: The aim of this study was to describe the diagnostic yield of endoscopic ultrasound (EUS) in patients with isolated elevated levels of amylase and/or lipase.
Methods A retrospective chart review was conducted at a large academic medical center from 2000 to 2016. Patients were selected based on having elevated amylase, lipase, or both, but without a diagnosis of pancreatitis or known pancreatobiliary disease. Patients were excluded if they had abnormal liver function tests or abnormal imaging of the pancreas.
Results Of 299 EUS procedures performed, 38 met inclusion criteria. Symptoms were present in 31 patients, most frequently abdominal pain (87%). In 20 patients (53%), initial EUS most commonly found chronic pancreatitis (n=7; 18%), sludge (5; 13%), or new diagnosis of pancreas divisum (3; 8%). In the asymptomatic patients (7), 3 had a finding on EUS, most importantly sludge (2), stone (1), and pancreas divisum (1). No patients were diagnosed with a mass or pancreatic cyst. During the follow up period, 6 patients (22%) had cholecystectomy.
Conclusions In our study of patients with isolated elevations in amylase and/or lipase without acute pancreatitis who underwent EUS, approximately 50% had a pancreatobiliary finding, most commonly chronic pancreatitis or biliary sludge.
Citations
Citations to this article as recorded by
Endosonographic features in patients with non-alcoholic early chronic pancreatitis improved with treatment at one year follow up Kazutoshi Higuchi, Seiji Futagami, Hiroshi Yamawaki, Makoto Murakami, Kumiko Kirita, Shuhei Agawa, Go Ikeda, Hiroto Noda, Yasuhiro Kodaka, Nobue Ueki, Keiko Kaneko, Katya Gudis, Ryuji Ohashi, Katsuhiko Iwakiri Journal of Clinical Biochemistry and Nutrition.2021; 68(1): 86. CrossRef
Do Patients with Pancreatic Hyperenzymemia without Abnormal Imaging Need Additional Endoscopic Ultrasound? Jung Wan Choe, Jong Jin Hyun Clinical Endoscopy.2019; 52(2): 97. CrossRef